Table 5.
pCa | WT | KO | ||
---|---|---|---|---|
krel (% decrease) | kdf (% decrease) | krel (% decrease) | kdf (% decrease) | |
6.2 | 66.5±3.8 | 55.7±3.5 | 63.2±3.0 | 40.2±4.5* |
6.1 | 57.9±2.4 | 30.2±5.7 | 76.4±3.0* | 30.1±3.0 |
6.0 | 50.8±1.6 | 26.3±4.8 | 61.7±2.7* | 27.3±2.7 |
5.9 | 41.8±2.3 | 18.6±3.3 | 60.9±1.9* | 24.3±3.7 |
krel: rate of XB detachment; kdf: rate of XB recruitment. Values are expressed as mean ± S.E.M. Paired t-tests were used to compare the data between pre- and post-OM treatment groups. 12–16 preparations were analyzed from 5 hearts and 13–18 preparations were analyzed from 7 hearts for WT and KO groups, respectively with multiple preparations from each heart. The decrease in krel was less pronounced as the level of activator [Ca2+] increased in the WT group but such a trend was absent in the KO group. The slowing in kdf was progressively decreased as the level of activator [Ca2+] increased in both the WT and KO groups. Furthermore, the % decreases in krel in the KO group were more pronounced than WT at pCa’s 6.1, 6.0, and 5.9. The % decreases in kdf in the WT group were significantly higher than KO at pCa 6.2. Correlation analysis showed a strong positive correlation between pCa vs. % decreases in krel and kdf in the WT group (correlation coefficient values of 0.99 and 0.93, respectively). In the KO group, there was a strong positive correlation between pCa vs. % decreases for kdf (correlation coefficient value of 0.94), and a moderate positive correlation for pCa vs. % decreases in krel in the KO group (correlation coefficient value of 0.38). This is due to the fact that the % decreases in krel in the KO group are less sensitive to increases in submaximal [Ca2+]. Independent t-tests were used to test the differences between WT and KO groups at each pCa.
Significantly different from the corresponding WT group; P < 0.05.